JNANA THERAPEUTICS
Jnana Therapeutics operates as a platform as a service company. It specializes in discovering and developing medicines that will make a difference for patients using the first drug discovery platform. It is a biotechnology company developing therapies that transform the lives of patients.
JNANA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.jnanatx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
100 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Current Advisors List
Current Employees Featured
Founder
Investors List
Versant Ventures
Versant Ventures investment in Series B - Jnana Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series B - Jnana Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Jnana Therapeutics
Polaris Partners
Polaris Partners investment in Series B - Jnana Therapeutics
Avalon Ventures
Avalon Ventures investment in Series B - Jnana Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Jnana Therapeutics
Versant Ventures
Versant Ventures investment in Series A - Jnana Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Jnana Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Jnana Therapeutics
Pfizer R&D Innovate
Pfizer R&D Innovate investment in Series A - Jnana Therapeutics
Key Employee Changes
Official Site Inspections
http://www.jnanatx.com Semrush global rank: 4.15 M Semrush visits lastest month: 2.88 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Jnana Therapeutics"
Jnana Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Jnana Therapeutics is a biotechnology company focused on discovering and developing medicines that improve patient lives. …See details»
Team - Jnana Therapeutics
Learn more about Jnana’s team of scientists and drug hunters who bring deep experience, bold ambition and a unified vision to deliver innovative therapies.See details»
Jnana Therapeutics - LinkedIn
Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemoproteomics RAPID platform to discover medicines for highly validated, challenging-to-drug targets ...See details»
Jnana Therapeutics Company Overview, Contact Details
Nov 15, 2022 Jnana Therapeutics, Inc. launches JNT-517. BOSTON, August 11, 2023 - Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation …See details»
Programs - Jnana Therapeutics
The biopharma industry has successfully drugged just a small fraction of the human proteome, leaving many diseases untreated. Jnana is leveraging its powerful RAPID platform to enable new possibilities for patients. We are …See details»
Jnana Company Profile - Office Locations, Competitors, Revenue
Jnana has 5 employees at their 1 location and $50 m in total funding,. See insights on Jnana including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Jnana Therapeutics - Overview, News & Similar companies
Jul 30, 2023 Jnana Therapeutics to Present at the Jefferies Healthcare Conference BOSTON, June 01, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company …See details»
Jnana Therapeutics to Present at 42nd Annual J.P. Morgan …
BOSTON, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover …See details»
Jnana Therapeutics Announces Appointment of John Throup, …
Jan 20, 2022 For more information, please visit www.jnanatx.com and follow us on Twitter and on LinkedIn. Contacts Media: Kathryn Morris The Yates Network 914-204-6412 …See details»
Jnana Therapeutics Announces Second Collaboration with Roche …
Nov 15, 2022 Jnana to leverage its RAPID chemoproteomics platform to discover novel small molecule drugs directed to targets across a diverse range of target classes in cancer, immune …See details»
Jnana Therapeutics Enters Collaboration with Roche to Discover …
Jul 21, 2020 For more information, please visit www.jnanatx.com and follow us on Twitter and on LinkedIn. Contacts. Kathryn Morris The Yates Network 914-204-6412 …See details»
Jnana Therapeutics Raises $107 Million to Advance Lead PKU …
Nov 15, 2022 For more information, please visit www.jnanatx.com and follow us on Twitter and on LinkedIn. About Bain Capital Life Sciences Bain Capital Life Sciences …See details»
Jnana Therapeutics Expands Leadership Team with Two …
Feb 3, 2021 For more information, please visit www.jnanatx.com and follow us on Twitter and on LinkedIn. Contacts Kathryn Morris The Yates Network [email protected] 914-204 …See details»
Jnana Therapeutics to Present at 42nd Annual J.P. Morgan
BOSTON, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover …See details»
Jnana Therapeutics Expands Leadership Team with Two …
Feb 3, 2021 Company appoints Nick Pullen, PhD, as Senior VP, Head of Biology and Brian Danieli as VP, Head of Finance & Operations. Boston, Mass. – February 3, 2021 – Jnana …See details»
Jnana Therapeutics Announces Positive Clinical Proof of Concept ...
BOSTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover …See details»
Jnana Therapeutics Announces Promotion of Joel Barrish, Ph.D., to ...
Nov 2, 2021 – Company co-founder and scientific leader will drive future growth of chemoproteomic product engine and pipeline programs – Boston, Mass., November 2, 2021 – …See details»
Jnana Therapeutics Reports Positive Topline Results from Phase 1a ...
May 31, 2023 JNT-517 demonstrated proof of mechanism and was safe and well tolerated in healthy volunteers Results support advancement to Phase 1b study in individuals with PKU; …See details»
Join Us - Jnana Therapeutics
The team at Jnana Therapeutics is driven by a shared purpose to deliver innovative therapies for the most challenging targets and diseases. Our name, Jnana, is a Sanskrit word meaning …See details»